FABP4 and type 2 diabetes mellitus: This role for hormonal FABP4 has been supported by studies using anti-FABP4 antibodies, which have demonstrated great therapeutic benefit in the treatment of both type 1 and type 2 diabetes in preclinical models (5, 10, 11).